Topic: Fibromyalgia syndrome

Introduction: Fibromyalgia syndrome (FMS) represents a complex and challenging condition characterized by widespread pain and an intricate interplay of genetic and environmental factors. Artificial intelligence (AI) offers the possibility of using previous knowledge to understand the molecular underpinnings of pain in FMS. The goal of this study was to leverage this information for drug repurposing prediction, setting the basis for new Clinical Trials. Methods: This study employed an innovative comprehensive approach utilizing AI for a systematic screening of genetic, clinical, and drug-relate